Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 916 results for "ranbaxy"

Buy Ranbaxy Labs; target of Rs 605: Motilal Oswal

Motilal Oswal is bullish on Ranbaxy Labs and has recommended buy rating on the stock with a target of Rs 605 in its July 29, 2014 research report. Money Control, 10 hours ago
Buy Ranbaxy at a target of Rs 603: Sandeep Wagle Economic Times, 6 days ago

988 images for ranbaxy

Money Today, 1 day ago
Financial Express, 2 days ago
ndtvimg.com, 1 day ago
MSN India, 2 days ago
4 Traders, 2 days ago
Livemint.com, 2 days ago
Pharma Letter, 1 day ago
Reuters India, 1 day ago
Livemint.com, 1 day ago
Livemint.com, 2 days ago

Expect upmove in Ranbaxy: Sudarshan Sukhani

Sudarshan Sukhani of s2analytics.com is of the view that one may see very large move on the upside in Ranbaxy Laboratories.
 Money Control11 hours ago Buy Lupin, Ranbaxy: Sudarshan Sukhani  Money Control2 weeks ago

CCI might ask Sun Pharma, Ranbaxy to divest products

CCI's direction might come wherever there is overlap and a potential threat of monopoly
 Business Standard22 hours ago CCI may ask Sun Pharma, Ranbaxy to divest products  India Infoline8 hours ago
Rediff.com

Sun Pharma to seek shareholders nod for Ranbaxy acquisition

Mumbai-based Sun Pharmaceutical Industries will seek shareholders nod for its USD 4 billion acquisition of Ranbaxy Laboratories in a court convened meeting on August 22.
 Business Standard1 day ago Sun to seek shareholders nod for Ranbaxy acquisition  Economic Times1 day ago Sun-ranbaxy deal gets nod  Asian Age1 week ago Sun Pharma-Ranbaxy merger gets BSE, NSE thumbs-up  Business Standard1 week ago
[x]  
Money Today

Ranbaxy reports Rs 185.92 cr net loss in Q1

Drug firm Ranbaxy Laboratories has reported a consolidated net loss of Rs 185.92 crore for the quarter ended June 30, 2014. The company had posted a net loss of Rs 524.24 crore for the corresponding period of the previous fiscal, Ranbaxy Laboratories said in ...
 Money Today1 day ago Ranbaxy suffers loss  The Telegraph1 day ago Ranbaxy Q1 net loss narrows to Rs 186 cr  Business Standard2 days ago Ranbaxy consolidated net loss at Rs 73.60 cr in Jan-Mar qtr  New Kerala2 months ago
[x]  

Stocks in news: ITC, LT, Bharti, Tata Steel, Ranbaxy, IDFC

ITC | Bharti Airtel | Larsen and Toubro | Sesa Sterlite | Ranbaxy Labs | Torrent Power | Dr Reddy's Labs | Tata Steel | Petronet LNG | Tata Global | State Bank Of Mysore | Aditya Birla Money | Inox Leisure | Prism Cement | VIP Industries | IDFC | Indiabulls ...
 Money Control1 day ago ITC, Bharti Airtel on traders’ radars  Business Line2 days ago
Business Standard

Ranbaxy hits 52-week high in volatile trade

Ranbaxy Laboratories rose 0.17% to Rs 591 at 11:21 IST on BSE after the company reported improved financial results for Q1 June 2014.
 Business Standard1 day ago Sun Pharma hits record high  EHealth Magazine3 weeks ago Ranbaxy extends gain on US FDA nod for Novartis's Diovan generic  Business Standard1 month ago Sell Ranbaxy; Sun Pharma may test Rs 780: Ranjit Kapadia  Money Control1 month ago
[x]  
Money Control

Here are top 10 stocks to focus on July 30

Here are top 10 stocks to focus on July 30 - LT, ITC, GMR Infra, Unitech, Bharti Airtel, Ranbaxy, Escorts, VIP, IDFC and Spicejet.
 Money Control1 day ago Top10 stocks to watch on July 14  Money Control2 weeks ago Top 10 stocks to watch on June 27  Money Control1 month ago
Business Standard

Provisions for settlement with US impact Ranbaxy's earnings

Sales from the North American market dipped 11% over a year to Rs 760 crore BS B2B Bureau | New Delhi July 30, 2014 Last Updated at 18:17 IST The Gurgaon-headquartered drug maker Ranbaxy Laboratories, undergoing an import ban imposed by the US drug regulator ...
 Business Standard1 day ago
Rediff.com

Ranbaxy provisions for settlement with US

Ranbaxy Laboratories, undergoing an import ban imposed by America’s drug regulator on the company’s four Indian factories, has made a one-time provision in its April-June financial earnings for a settlement with the US government. The Gurgaon-headquartered drug maker, set to be acquired by another leading domestic company, Sun Pharmaceutical Industries, reported a consolidated net loss of Rs 186 crore for the quarter ended June. It had posted a net loss of Rs 524 crore (Rs 5.24 ...
 Rediff.com1 day ago Generic drug settlement brings healthy round of funds to Oregon  Big News Network3 weeks ago Avanir Settles With Ranbaxy Over Nuedexta Generic  FDA News4 weeks ago Oregon Settles With Indian Drug Company For $2.3M  Oregon Public Broadcasting3 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - ranbaxy
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less